首页> 外文期刊>Journal of Hainan Medical University >Effect of bisoprolol in combined with trimetazidine on the cardiac function rehabilitation in patients with chronic heart failure
【24h】

Effect of bisoprolol in combined with trimetazidine on the cardiac function rehabilitation in patients with chronic heart failure

机译:比索洛尔联合曲美他嗪对慢性心力衰竭患者心功能康复的影响

获取原文
       

摘要

Objective: To explore the effect of bisoprolol in combined with trimetazidine on the cardiacfunction rehabilitation in patients with chronic heart failure (CHF). Methods: A total of 84patients with CHF who were admitted in our hospital from November, 2015 to October,2016 were included in the study and randomized into the observation group and the controlgroup. The patients in the two groups were given oxygen inhalation, lipid regulation, diuresis,ARB, and other routine treatments. Digitalis preparations were given for those who had poorcardiac function, and bisoprolol were orally administrated in the same time. On the abovebasis, the patients in the observation group were given trimetazidine dihydrochloride tablets,continuously for 3 months. The morning fasting peripheral venous blood before and aftertreatment in the two groups was collected. CRP, IL-6, TNF-α, BNP, NE, AngⅡ, ANP, ALD,and ET were detected. The cardiac color Doppler ultrasound diagnostic apparatus was used todetect LVPWT, PWS, PWD, IVSS, and IVMI. Results: CRP, IL-6, TNF-α, and BNP levelsafter treatment in the observation group were significantly lower than those in the controlgroup. NE, AngⅡ, ANP, ALD, and ET levels after treatment in the observation group weresignificantly lower than those in the control group. LVPWT, PWS, PWD, IVSS, and IVMIlevels after treatment in the observation group were significantly lower than those in the controlgroup. Conclusions: Bisoprolol in combined with trimetazidine can significantly reducethe inflammatory reaction in patients with CHF, and effectively regulate the neuroendocrinestability in order to reverse or reduce VR and improve the left ventricular function.
机译:目的:探讨比索洛尔联合曲美他嗪对慢性心力衰竭(CHF)患者心功能康复的影响。方法:将2015年11月至2016年10月在我院收治的84例CHF患者纳入研究,随机分为观察组和对照组。两组患者均接受了氧气吸入,脂质调节,利尿,ARB和其他常规治疗。为那些心功能不全的人提供了洋地黄制剂,并且比索洛尔同时口服。在上述基础上,观察组患者连续给予曲美他嗪二盐酸盐片3个月。两组均于治疗前及治疗后早晨禁食外周静脉血。检测了CRP,IL-6,TNF-α,BNP,NE,AngⅡ,ANP,ALD和ET。心脏彩色多普勒超声诊断仪用于检测LVPWT,PWS,PWD,IVSS和IVMI。结果:观察组治疗后CRP,IL-6,TNF-α和BNP水平明显低于对照组。观察组治疗后的NE,AngⅡ,ANP,ALD和ET水平明显低于对照组。观察组治疗后的LVPWT,PWS,PWD,IVSS和IVMI水平显着低于对照组。结论:比索洛尔联合曲美他嗪可明显减轻CHF患者的炎症反应,并有效调节神经内分泌能力,从而逆转或降低VR,改善左心室功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号